CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL)
Background: the expression of CD30, CD15, CD50, and PAX5 are used to help in confirming diagnosis of HL and sALCL; however data on the proportion of these markers have not been available. The study was aimed to identify the proportion of CD30, CD15, CD50 and PAX5 expressions and characteristics of p...
Saved in:
Main Authors: | Dody Ranuhardy, Evlina Suzanna, Resti M Sari, Dwi W Hadisantoso, Rizka Andalucia, Arif Abdillah |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2018-06-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://actamedindones.org/index.php/ijim/article/view/662 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL)
by: Dody Ranuhardy, et al.
Published: (2018-06-01) -
Determination of morphology and immunophenotype of circulating lymphoma cells in patients with splenic marginal zone lymphoma using an anti-CD antibody microarray
by: A. N. Khvastunova, et al.
Published: (2017-04-01) -
Prospects for predicting the course of nodular sclerosis Hodgkin lymphoma by morphometric analysis of CD163-positive macrophages
by: M. S. Minaev, et al.
Published: (2021-04-01) -
Value of CD5 and CD79 in Evaluation of GIT Lymphoma
by: Huda Mohammed Abdulwahid, et al.
Published: (2025-04-01) -
Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults
by: N. E. Konoplya, et al.
Published: (2023-09-01)